ストックスクリーナーアプリを入手
1.84
1.10%
0.02
前日終値:
$1.82
開ける：
$1.86
24時間の取引高:
48,776
Relative Volume:
1.64
時価総額：
$5.86M
収益：
$8,700
当期純損益:
$-8.49M
株価収益率:
-0.3732
EPS:
-4.9303
ネットキャッシュフロー:
$-7.39M
1週間 パフォーマンス:
-2.13%
1か月 パフォーマンス:
-1.08%
6か月 パフォーマンス:
-15.98%
1年 パフォーマンス:
-47.73%
1日の値動き範囲:
$1.8001
$1.9399
1週間の範囲:
$1.74
$2.085
52週間の値動き範囲:
$1.63
$6.47
Heartsciences Inc Stock (HSCS) Company Profile
Compare HSCS vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HSCS
Heartsciences Inc
|
1.84 | 5.86M | 8,700 | -8.49M | -7.39M | -4.9303 |
ABT
Abbott Laboratories
|
88.41 | 153.99B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.80 | 118.00B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
79.34 | 101.86B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
45.29 | 67.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.36 | 50.30B | 6.30B | 1.07B | 1.09B | 1.8406 |
Heartsciences Inc (HSCS) 最新ニュース
HeartSciences Inc (HSCS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
HeartSciences Inc (HSCSW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
HeartSciences Inc (HSCS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
HeartSciences Inc (HSCS) Valuation: PE, PB & Fair Value Analysis - TradingKey
HeartSciences Inc (HSCS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
HeartSciences Inc (HSCS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
HeartSciences Inc (HSCS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
HeartSciences Inc (HSCSW) Valuation: PE, PB & Fair Value Analysis - TradingKey
HeartSciences Inc (HSCS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
HeartSciences Inc (HSCS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
HeartSciences Inc (HSCSW) Institutional Confidence - TradingKey
HeartSciences Inc (HSCSW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
HeartSciences Inc (HSCSW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
HeartSciences Inc (HSCSW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
HeartSciences Inc (HSCSW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
HeartSciences Inc (HSCSW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
HeartSciences Inc (HSCSW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
HSCS Q1 2026 Earnings: EPS Beat Surprise of 27% on Lower-Than-Expected Loss, No Revenue ReportedGrowth Acceleration Report - newsline.com
HeartSciences Granted European Patent for Electrocardiography Technology; Shares Fall - marketscreener.com
AI ECG heart test secures patent protection in 19 European countries - Stock Titan
European Patent Granted for ECG-Based Assessment of Diastolic Function, Expands HeartSciences’ Patent Portfolio to More Than 45 Granted Patents - The Manila Times
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
HeartSciences Inc. Financial Disclosures & SEC Filings - TradingView
HeartSciences Launches New Version of MyoVista Insights with AI-ECG - dicardiology.com
HeartSciences Launches MyoVista Insights™ Version 1.3 with AI-ECG Algorithm Marketplace and First FDA-Cleared Algorithm - The Manila Times
AI heart scan helping spot heart failure risk earns $136 Medicare payment - Stock Titan
HeartSciences Inc. (HSCS) Q1 2026 Earnings: EPS Surprise Beats Estimates Amid Pre-Revenue Operational Progress - newsline.com
HeartSciences Inc. (HSCS) Slides 6.96% as Stock Approaches Critical Support at $1.59Dealer Positioning - The Legal Advocate
HeartSciences Warrants (HSCSW) Remain Flat at $0.05 as Support and Resistance CoincideDark Pool Prints - newsline.com
HeartSciences Inc. (HSCS) Declines Over 7% as Stock Tests Key Support Near $1.70Early Entry Signals - The Legal Advocate
HeartSciences Inc. (HSCS) Slips 2.5% as Shares Test Key Support ZoneProfit Surge Picks - The Legal Advocate
HeartSciences Inc. Warrant (HSCSW) Slides 15.50% as Price Narrows to $0.05TPO Profile - The Legal Advocate
HeartSciences Inc. Warrant (HSCSW) Slides 15% as Price Hovers at Key $0.05 LevelPut Flow Alert - The Legal Advocate
HeartSciences Inc. (HSCS) Q1 2026 Earnings: Wider-Than-Expected Loss Narrows on Strong Cost Control, Shares RallyAdjusted Earnings Analysis - The Legal Advocate
HSCS Q1 2026 Earnings: EPS Surpasses Estimates as HeartSciences Advances Development PipelineEarnings Growth Analysis - newsline.com
HeartSciences signs North Shore Health for MyoVista platform - Investing.com UK
HeartSciences signs North Shore Health for MyoVista platform By Investing.com - Investing.com Nigeria
Rural Minnesota hospital adopts AI ECG platform endorsed by 127-hospital network - Stock Titan
HeartSciences (HSCS) Rallies +3.99% as Bulls Target $1.94 2026-05-18Undervalued Stocks - newsline.com
HeartSciences Stockholders Approve Director Election and Equity Plan - TipRanks
HeartSciences (HSCSW) Stalls at $0.06 — Breakout or Breakdown? 2026-05-17Fibonacci Entry Signals - newsline.com
HeartSciences (HSCS) Reports Strong Q1 2026 — Revenue $N/A, EPS BeatsMarket Hype Signals - newser.com
TradingKey - TradingKey
HeartSciences (HSCS) Stock: Slides -3.53%, Support at $1.74 2026-05-14Gamma Alerts - Newser
HeartSciences (HSCSW) Stalls at $$0.06 — Breakout or Breakdown? 2026-05-14Collaborative Trading Signals - newser.com
What HeartSciences (HSCS) accounting reveals about the business | Q1 2026: EPS Tops ViewsCommunity Volume Signals - newser.com
What HeartSciences (HSCSW) disclosed about liquidity position | HSCSW Q3 Earnings: HeartSciences Warrant Shows No Revenue DataEarnings Risk - Newser
HSCSW Q3 Earnings: HeartSciences Warrant Shows No Revenue DataQuarterly Financial Update - The Legal Advocate
The technology investments behind HeartSciences (HSCSW) growth | HSCSW Q1 Earnings: HeartSciences Revenue Data UnavailableFinancial Health - Newser
HSCSW HeartSciences quarterly results show strategic progress as innovation pipeline drives growth, CEO upbeat on outlook.Cyclicality - newser.com
HeartSciences Inc. 2026 Annual Meeting 8-K Filing: Company Details, Stockholder Votes, and Corporate Governance Updates - Minichart
Heartsciences Inc (HSCS) 財務データ
収益
当期純利益
現金流量
EPS
0.93%
大文字化:
|
ボリューム (24 時間):